Ignite Creation Date:
2024-05-06 @ 7:00 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05853835
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2023-04-28
Brief Title:
First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety Tolerability and PK of LAPIX Study Drug LPX-TI641
Sponsor:
LAPIX Therapeutics Inc
Organization:
LAPIX Therapeutics Inc
Organization Data
Organization:
LAPIX Therapeutics Inc
Class:
INDUSTRY
Study ID:
LPX641-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LAPIX Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None